Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit
Completed
- Conditions
- COVID-19-Associated Thromboembolism
- Registration Number
- NCT06037707
- Lead Sponsor
- Ayse Zeynep Turan
- Brief Summary
The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.
- Detailed Description
Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 484
Inclusion Criteria
- Patients who were infected with COVID-19 and admitted to the intensive care unit between the time of March 2020-December 2021
Exclusion Criteria
- who is under 18 years old.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease During the entire intensive care stay up to 1 day Both arterial and venous thromboembolic events were detected
- Secondary Outcome Measures
Name Time Method Rate of thromboembolic complications of COVID-19 disease in critically ill patients During the entire intensive care stay up to 1 day Both arterial and venous thromboembolic events were detected
What is the rate of thromboembolism according to the comorbidities During the entire intensive care stay up to 1 day Comorbidities of each patient were recorded from the patients records.
Rate of thromboembolic complications according to anticoagulant therapy During the entire intensive care stay up to 1 day Antithrombotic therapy of each patient was recorded
Trial Locations
- Locations (1)
Derince Research and Training Hospital
🇹🇷Kocaeli, Derince, Turkey